Doc.com
Doc.com is a digital health company providing telemedicine consultations. Notable features include an AI-powered vital scan and prescription delivery services.
Secondary Market Price
How Doc.com Measures Up
To help you manage your Doc.com equity, Prospect has run the company through our machine learning model.
Prospect Rating
--
This rating reflects our belief in this company's potential to grow to that many times its current value in 4 years. For an employee with stock, this rating suggests a potential return on equity, but it also comes with some risk.
Exit Risk
--
Our rating is a reflection of the likelihood of this company achieving a liquidity event for its employees based on the quality of investors, funding stage, founders, and more.
Funding Stage
TBD
A company’s funding stage reflects how established it is, how quickly it is scaling, and the average impact an employee may have when joining.
Secondary Market Price Chart
Create a free account to unlock real-time secondary market prices and future projections of Doc.com's value.
Sign up to Unlock the Latest DataData will be available soon.
Sign up to receive notifications when it is available.
Prospect Projected Future Doc.com Prices
Prospect’s machine learning model has been trained on the same data top-tier investors use to project the likely range of outcomes for Doc.com's equity. Create a free account to view 10th-90th percentile projections over 2, 4, and 6 years.
Powerful tools to earn more from your equity
Company Description
Doc.com is a digital health company that offers telemedicine services connecting users with licensed medical, psychological, and veterinary professionals. The platform operates 24/7, does not require insurance, and provides services such as AI-driven symptom assessment, vital sign scanning through a device's camera, and prescription delivery. It uses blockchain technology for security. While specific details about the company's founding date and early history are not provided in public materials, Charles Nader is identified as the company's CEO.
The company's forward-looking strategy centers on expanding its artificial intelligence capabilities and pursuing its mission to make basic telemedicine accessible on a global scale. Recent company announcements align with this focus, including a December 2024 statement about expanding its AI developments and a February 2025 announcement regarding a new leadership team tasked with driving its global healthcare initiatives.
- Silver Rock Group
- Co-Founder, Charles Nader
- Co-Founder, Isao Hojyo
Peer Group Comparison
Vs Peer Group of >$4B Startups
Frequently Asked Questions
Joining Anduril as an employee is another way to acquire equity, typically through stock options included in compensation packages.
Is Doc.com worth joining?
Deciding whether to join Doc.com depends on your personal career goals and how you evaluate the company's potential, culture, and compensation package. Tools like Prospect can help you analyze the value of the equity component of your offer to make a more informed decision.
What should I do with my Doc.com stock?
Managing your Doc.com equity involves complex financial decisions, including when to exercise options and how to plan for taxes. Using a platform designed for startup equity management can help you create a personalized strategy to maximize its potential value.
Can you sell Doc.com stock?
Since Doc.com is a private company, its stock is not traded on a public exchange and is generally difficult to sell. Opportunities to sell may arise through company-approved secondary market transactions or tender offers, which platforms like Prospect can help you navigate.
How can I find the value of my Doc.com stock?
The official value of private stock is determined by a 409A valuation, which establishes the fair market value for tax and accounting purposes. To understand its potential future worth, you can use specialized tools that model different outcomes for your startup equity.
What is Doc.com's equity worth?
The total valuation of a private company like Doc.com is determined by its latest funding round or internal 409A valuation. For an individual, understanding the potential worth of your specific grant requires modeling future scenarios, which is a core feature of equity management platforms.
What is Doc.com's stock ticker symbol?
Doc.com does not have a stock ticker symbol because it is a private company and its shares are not traded on a public stock exchange. Ticker symbols are only assigned to companies after they complete an Initial Public Offering (IPO).
Can I buy or sell Doc.com stock?
As a private company, Doc.com stock is not available for purchase by the general public on an open market. Selling shares is also highly restricted and typically only possible during specific events like tender offers, which tools like Prospect can help you evaluate.
What is the criteria to buy or invest in Doc.com stock?
Investing in a private company like Doc.com is typically restricted to accredited investors and venture capital firms during official fundraising rounds. Employees may also acquire equity as part of their compensation package, which they can manage using specialized equity management tools.
